![](/img/cover-not-exists.png)
The One Health Consortium: Design of a Phase I Clinical Trial to Evaluate M032, a Genetically Engineered HSV-1 Expressing IL-12, in Combination With a Checkpoint Inhibitor in Canine Patients With Sporadic High Grade Gliomas
Chambers, M. R., Bentley, R. Timothy, Crossman, David K., Foote, Jeremy B., Koehler, Jey W., Markert, James M., Omar, Nidal B., Platt, Simon R., Self, D. Mitchell, Shores, Andy, Sorjonen, Donald C., WVolume:
7
Journal:
Frontiers in Surgery
DOI:
10.3389/fsurg.2020.00059
Date:
August, 2020
File:
PDF, 668 KB
2020